Caspian Sunrise plc (AIM:CASP)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	51	56	95	106	47	147
Market Cap Growth	-4.22%	-40.48%	-10.44%	124.62%	-68.00%	21.22%
Enterprise Value	56	53	86	105	47	144
Last Close Price	0.02	0.03	0.04	0.05	0.02	0.08
PE Ratio	10.88	6.77	11.58	-	-	-
Forward PE	-	55.00	55.00	55.00	55.00	55.00
PS Ratio	1.69	1.96	2.79	5.72	4.49	16.06
PB Ratio	0.98	1.08	2.08	3.13	1.12	3.54
P/TBV Ratio	0.92	1.00	1.88	2.78	1.02	3.21
P/FCF Ratio	-	-	17.85	-	-	98.18
P/OCF Ratio	22.12	12.66	6.21	18.44	-	22.96
EV/Sales Ratio	1.86	1.86	2.55	5.71	4.45	15.72
EV/EBITDA Ratio	4.87	3.88	6.90	12.52	218.82	-
EV/EBIT Ratio	6.96	4.55	8.48	18.20	-	-
EV/FCF Ratio	-6.27	-	16.33	-	-	96.11
Debt / Equity Ratio	0.18	0.10	0.01	0.14	0.10	0.07
Debt / EBITDA Ratio	0.81	0.38	0.02	0.56	19.24	-
Debt / FCF Ratio	-	-	0.06	-	-	2.04
Asset Turnover	0.28	0.29	0.35	0.21	0.11	0.13
Inventory Turnover	7.25	16.01	15.08	10.65	12.54	-
Quick Ratio	0.39	0.29	0.35	0.14	0.17	0.30
Current Ratio	0.49	0.50	0.37	0.21	0.27	0.36
Return on Equity (ROE)	10.37%	18.34%	19.85%	-10.79%	-6.23%	-3.08%
Return on Assets (ROA)	4.65%	7.40%	6.63%	4.08%	-0.69%	-0.90%
Return on Capital (ROIC)	9.01%	14.59%	14.33%	8.53%	-1.43%	-1.78%
Return on Capital Employed (ROCE)	9.60%	14.00%	13.40%	9.10%	-	-
Earnings Yield	8.81%	14.78%	8.64%	-3.89%	-5.32%	-0.66%
FCF Yield	-17.51%	-9.16%	5.60%	-0.07%	-9.79%	1.02%
Dividend Yield	-	3.45%	2.00%	-	-	-
Payout Ratio	0.02%	28.57%	11.15%	-	-	-
Buyback Yield / Dilution	0.57%	-1.41%	-5.88%	-12.11%	-2.54%	-9.30%
Total Shareholder Return	-	2.04%	-3.88%	-12.11%	-2.54%	-9.30%

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.